In other words, β2GPI-dependent antibodies are responsible for positive results in the two solid-phase assays that are the formal laboratory classification criteria for APS, namely aCL and anti-β2GPI antibody tests. The gene discussed is ACLY; the disease is autoimmune polyendocrinopathy.